Page 8 - சந்தேற மருந்துகள் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Santhera Reports Interim Results on Convertible Bond Exchange Offer Santhera Pharmaceuticals Holding AGApril 20, 2021 GMT NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, April 20, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that so far an aggregate principal value of around CHF 39.6 million, or 66% of its CHF 60 Million Convertible Bonds, have been accepted for exchange under the Exchange Offer announced on March 25, 2021. Bondholders who have not yet accepted the Exchange Offer will be able to do so during the additional acceptance period ending on April 27, 2021, 5:00 p.m. CEST. In parallel to the Exchange Offer, voting on the bondholders’ resolution continues.

Switzerland generalUnited statesUnited kingdomEva kaliasSanthera pharmaceuticalsNeither the companySwiss financial services act finHead external communicationsNotice the exchangeFinancial servicesSanthera pharmaceuticals holdingUs securities exchangeStifel nicolaus europeEuropean union withdrawalChiesi groupHighbridge tactical credit master fund